Chancellor Rachel Reeves Plans Focused Action on Living Costs in Forthcoming Budget

Chancellor Reeves has revealed she is preparing "targeted measures to tackle cost of living pressures" in the upcoming financial statement.

In comments to the BBC, she stated that lowering inflation is a shared responsibility of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the G7 developed nations this calendar year and next.

Possible Energy Bill Interventions

It is understood the administration could take action to reduce utility costs, such as by reducing the current 5% rate of value-added tax applied on energy.

A further option is to lower some of the regulatory levies currently added to bills.

Budgetary Constraints and Analyst Predictions

The administration will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for these actions.

The expectation from the majority of economists is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her declared borrowing rules.

Earlier on Thursday, analysis showed there was a £22bn shortfall for the Treasury chief to resolve, which is at the lower end of forecasts.

"There's a shared responsibility between the Bank of England and the administration to further reduce some of the drivers of price increases," Reeves informed reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and International Issues

While much of the focus has been on expected tax rises, the chancellor said the latest figures from the OBR had not changed her pledge to election pledges not to raise rates on income tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with increasing international and commercial concerns for the Budget revenue measures, likely to be directed on those "wealthiest."

International Trade Disputes

Referring to concerns about the United Kingdom's trade ties with China she said: "Our national security always are paramount."

Last week's declaration by Chinese authorities to increase export controls on critical minerals and other resources that are crucial for advanced tech manufacturing led US President Donald Trump to suggest an additional 100% import tax on imports from the Asian country, increasing the possibility of an full-scale trade war between the two largest economies.

The US Treasury Secretary described China's action "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to join its dispute with the Asian nation, Reeves said she was "very concerned" by Chinese measures and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "damaging for the international commerce and generates further challenges."

"I believe there are areas where we should address China, but there are also valuable chances to trade with China's economy, including financial services and other sectors of the economic system. We've got to achieve that balance correct."

The chancellor also affirmed she was working with other major economies "regarding our own essential resources approach, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also admitted that the cost the National Health Service spends on medicines could rise as a result of current discussions with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning investments in the UK, with some attributing the insufficient payments they are receiving.

Last month, the Science Minister said the price the NHS spends on drugs would need to rise to prevent businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to media: "We have seen as a result of the pricing regime, that drug testing, innovative medicines have not been offered in the UK in the manner that they are in other European countries."

"Our aim is to make sure that patients receiving care from the National Health Service are can access the finest life-saving treatments in the globe. And so we are examining all of that, and... seeking to attract increased funding into the UK."